Your virtual partner in cardiac care
Our services are in addition to your care, and focus on close remote monitoring and expediting guideline-directed medical therapy for patients with heart failure and other conditions.
Learn more
Virtually complementing your care
As a virtual network, we enhance your practice’s ability to see and treat patients by providing your eligible heart failure patients with a 4-month post-diagnosis program.
- Remote patient monitoring and triage services
- Full GDMT titration and diuretic optimization
- In-depth patient education and support
- Medication authorization and assistance support
Boost patient outcomes and practice productivity
We provide fast access to optimal GDMT, helping your patients feel better while increasing your practice productivity.
-
Lower readmissions and mortality
- 70% lower readmissions for patients with HFrEF when on optimal GDMT1
- 8 years added to patient’s life on average by going from 2 to 4 GDMT medications2
-
Improved practice productivity
- Reduce time spent on medication titration and authorizations
- More capacity for new patients and in-person diagnostics and procedures
Our care model delivers results
Results from our pilot studies demonstrate improved outcomes, high satisfaction, and decreased healthcare utilization.1
High adherence
92% appointment show rate
87% recorded daily weight
High engagement
21 pt increase in KCCQ-12 score
99% patient satisfaction
High impact
70% of appointments resulted in heart failure medication titration
90% decrease in heart failure admissions in 4 months pre- vs. post-intervention
Our evidence-based care model addresses gaps in current clinical practice
Remote Monitoring for Heart Failure Management at Home: JACC Scientific Statement
“Early telemonitoring of weights and symptoms did not decrease heart failure hospitalizations... Remote monitoring coupled with a system of care that engages, informs, and empowers patients is essential for effective home management of heart failure to control symptoms, avoid hospitalization, and ameliorate the patient’s perception of illness.”
A Systematic Review and Network Meta-Analysis of Pharmacological Treatment of Heart Failure with Reduced Ejection Fraction
Optimizing to four GDMT medications reduces mortality by 70%
5 years increase in life expectancy when on optimal GDMT
Safety, Tolerability, and Efficacy of Up-Titration of Guideline-Directed Medical Therapies for Acute Heart Failure (STRONG-HF): A Multinational, Open-Label, Randomised Trial
Aggressive GDMT titration within weeks of heart failure discharge improves patient outcomes
34% reduction in heart failure death and readmission
Opportunities and Achievement of Medication Initiation Among Inpatients with Heart Failure with Reduced Ejection Fraction
Gaps remain in initiating evidence-based medications
1 in 3 visits to a cardiology clinic led to a GDMT addition or titration for heart failure patients
High patient satisfaction
Confidently refer your patients to Ventricle, knowing they’ll receive the highest quality care.
“They took very good care of me.
They were concerned about my health.”
—Ventricle patient
Partner with us
1Bensimhon, D. (2024, March 4-6). High Frequency Virtual Cardiology Intervention (HF-VCI) in implementing Heart Failure Guideline-Directed Medical Therapy (HF-GDMT) [Conference session]. Technology and Heart Failure Therapeutics, Cardiovascular Research Foundation® (CRF®), Boston, MA, United States. https://www.tctmd.com/slide/high-frequency-virtual-cardiology-intervention-hf-vci-implementing-heart-failure-guideline 2Vaduganathan M, Docherty KF, Claggett BL, et al. SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials [published correction appears in Lancet. 2023 Jan 14;401(10371):104. doi: 10.1016/S0140-6736(23)00018-1]. Lancet. 2022;400(10354):757-767. doi:10.1016/S0140-6736(22)01429-5